To help women make informed choices about their health, an FDA study has found that U.S. marketed tampons do not pose a health risk from toxic metal exposure. It was conducted after an outside report in 2024 found metals in tampons but didn’t assess harm. Read the results:
Learn how FDA’s Center for Biologics Evaluation and Research (CBER), responsible for regulation of the nation’s blood supply, evaluates Biologics License Applications in its effort to maintain the U.S blood supply: fda.gov/news-events/pu…
FDA continues to work with stakeholders
As we prepare to celebrate America's 250th birthday, National Autism Coordinator Diana Diaz-Harrison and I have an important message for the autism community: stay vigilant around water.
Many autistic individuals are naturally drawn to water, and drowning remains a leading cause
Join us for FDA Grand Rounds on July 9th. FDA’s Human Foods Program will present on an analysis of Shigatoxigenic E. coli prevalence in surface waters, sediment, soil, air and animal feces sampled across the Central Coastal agricultural growing region of California.
NEWS: @US_FDA’s Center for Veterinary Medicine released a 3-year strategic plan to improve the availability of safe and effective drugs for underserved animal populations.
See more: fda.gov/animal-veterin…
FDA has selected 7 companies for the new PreCheck Pilot Program — a first-of-its-kind initiative to strengthen domestic drug manufacturing, boost U.S. supply chain resilience, and help get more affordable medicines to patients faster. #MadeInAmerica
By embedding FDA expertise earlier in the facility development process, we're cutting costly delays and giving manufacturers a clearer, more predictable path to market. Learn more:
FDA launched the Phase 1 Investigational New Drug (IND) Navigator, a centralized webpage consolidating tools, guidances, educational resources, and regulatory information from CDER (@FDA_Drug_Info) and @FDACBER. To learn more, visit: fda.gov/industry/phase…
The Navigator was launched as part of our actions to accelerate and modernize early and late-stage clinical development. This new resource is designed to help sponsors prepare and submit Phase 1 IND applications:
Thank you, @POTUS, for signing this landmark Executive Order to scale regenerative agriculture and advance the Make America Healthy Again agenda.
On Thursday, @SecRollins and I joined President Trump alongside America's leading regenerative farmers because healthier food starts
Update: The FDA continues to observe unreliable testing data generated by third-party testing facilities on behalf of device manufacturers and sponsors.
fda.gov/medical-device…
Guys! Listen up! Did you know that men die every day from heart disease that could be prevented? Do something about it before it’s too late. Stop smoking. Eat better. Move around.
fda.gov/consumers/heal…#MensHealthMonth#HeartDisease#FDA
Misinformation about #sunscreen is spreading online — and dermatologists are sounding the alarm.
Here's what science actually says:
✅ Routine sunscreen use has NOT been shown to cause vitamin D deficiency
✅ SPF 15+ broad spectrum sunscreens, when used as directed with other
This week, FDA, NIH, CMS, ONC, ARPA-H, and the HHS Office of Inspector General launched a coordinated effort to strengthen America's clinical research enterprise and bring more clinical research and investment back to the United States.
The FDA is working to expand available prevention and treatment options for New World screwworm (NWS). fda.gov/animal-veterin…
Explore FDA's growing list of conditionally approved and authorized animal drugs and learn how these tools support response efforts and can protect